Absentéisme en entreprise : près d'un salarié du privé sur trois a connu un arrêt de travail en 2025 selon l'étude 2026 de Malakoff Humanis

L’étude 2026 de Malakoff Humanis indique une installation durable de l’absentéisme à un niveau élevé dans les entreprises françaises, analysée à partir des données anonymisées de 3,8 millions de salariés et de plus de 300 000 dossiers d’arrêts longs indemnisés. Le baromètre IFOP (3 000 salariés, 400 dirigeants, 200 médecins généralistes) suggère une transformation structurelle du phénomène, ce qui constitue un signal de coûts et de risques opérationnels potentiels pour les entreprises.

Analysis

This reads less like a one-off labor headline and more like a slow burn productivity tax on France Inc. The market mechanism is margin dilution: if absenteeism remains structurally elevated, domestic employers either absorb lower utilization or pay up for overtime, temporary labor, and manager time — all of which are harder to pass through in consumer-facing and regulated businesses. The first-order hit is to labor-intensive sectors with tight operating leverage: retail, transport, healthcare services, hospitality, and industrials with French plant footprints.

The second-order winner set is more interesting than the obvious losers. Temporary staffing, workforce management, occupational health, and employee-benefits intermediaries should see incremental demand as companies formalize substitution labor and prevention spend; in Europe that favors names with French SME exposure rather than pure global cyclicals. Meanwhile, insurers and mutuals with group health/absence products may face claims pressure in the short run but can reprice in renewals over 6-18 months, so the net impact is likely mixed rather than immediately negative.

The consensus risk is treating this as a static HR issue instead of a compounding earnings revision story. If absenteeism stays elevated through the next earnings season, French domestic names will get hit through lower same-store productivity before revenue shows obvious weakness; that usually compresses margins first and multiples later. The main falsifier is a visible mean reversion in labor attendance or a policy/medical intervention that lowers long-duration claims over the next 1-2 quarters.

Key Decisions for Investors

• Watchlist, not a forced trade: short French domestically exposed labor-intensive names on earnings weakness only if management teams start flagging overtime, temp labor, or service-level slippage; best candidates are French retail, transport, and industrial operators with high local headcount.
• Long staffing/HR substitution beneficiaries over 3-6 months: preferred expression is a basket long of RAND.AS and ADEN.SW versus short the CAC 40 consumer/services segment, on the thesis that persistent absenteeism forces more contingent labor usage.
• If you need a cleaner relative-value hedge, pair long European workforce-management/software exposure against short French cyclicals with low pricing power; the setup improves if Q1/Q2 guidance starts referencing labor inefficiency rather than demand weakness.
• Alert on French group-benefits/health underwriting renewals over the next 6-12 months: any visible pricing re-rate would support AXA-style diversified insurers more than pure domestic mutuals, but near-term claims noise makes this a lower-conviction trade.